• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解剖性肝切除术治疗早期肝细胞癌是否必要?单中心回顾性经验。

Is anatomical resection necessary for early hepatocellular carcinoma? A single institution retrospective experience.

机构信息

Department of Medical Statistics & Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, PR China.

Department of Hepatobiliary & Pancreatic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Shenzhen, PR China.

出版信息

Future Oncol. 2019 Jun;15(17):2041-2051. doi: 10.2217/fon-2019-0117. Epub 2019 Apr 10.

DOI:10.2217/fon-2019-0117
PMID:30968698
Abstract

The present study aimed to determine whether anatomical resection was necessary for early hepatocellular carcinoma. A log-rank test or two-stage test was used for univariate analysis. A Cox proportional hazards model was used for multivariable analysis. For patients without microvascular invasion, a resection margin ≥1 cm provided the longest recurrence-free survival time regardless of whether they underwent anatomical resection (p = 0.005) or nonanatomical resection (p = 0.006). For patients with microvascular invasion, anatomical resection combined with a resection margin ≥1 cm provided the longest recurrence-free survival time compared with other treatments (p = 0.001). Anatomical resection was not necessary for patients without microvascular invasion. However, for patients with microvascular invasion, both anatomical resection and a resection margin ≥1 cm were necessary.

摘要

本研究旨在确定解剖性肝切除术是否对早期肝细胞癌有必要。采用对数秩检验或两阶段检验进行单因素分析。采用 Cox 比例风险模型进行多因素分析。对于无微血管侵犯的患者,无论行解剖性肝切除术(p = 0.005)还是非解剖性肝切除术(p = 0.006),切缘≥1 cm 提供了最长的无复发生存时间。对于有微血管侵犯的患者,与其他治疗方法相比,解剖性肝切除联合切缘≥1 cm 提供了最长的无复发生存时间(p = 0.001)。对于无微血管侵犯的患者,解剖性肝切除术并非必要。然而,对于有微血管侵犯的患者,解剖性肝切除和切缘≥1 cm 均是必要的。

相似文献

1
Is anatomical resection necessary for early hepatocellular carcinoma? A single institution retrospective experience.解剖性肝切除术治疗早期肝细胞癌是否必要?单中心回顾性经验。
Future Oncol. 2019 Jun;15(17):2041-2051. doi: 10.2217/fon-2019-0117. Epub 2019 Apr 10.
2
A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion.广泛肝切除术可改善伴有微血管侵犯的 HBV 相关肝细胞癌患者的长期预后。
Surgery. 2019 Apr;165(4):721-730. doi: 10.1016/j.surg.2018.09.016. Epub 2018 Dec 13.
3
Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.无肉眼可见血管侵犯的孤立性肝细胞癌的解剖性切除与非解剖性切除:一项倾向评分匹配分析
J Gastroenterol Hepatol. 2017 Apr;32(4):870-878. doi: 10.1111/jgh.13603.
4
Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis.解剖性切除及宽切缘在伴有肿瘤周围微转移的肝细胞癌肝切除术中起着重要作用。
ANZ J Surg. 2019 Nov;89(11):E482-E486. doi: 10.1111/ans.15396. Epub 2019 Oct 16.
5
Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.术后辅助经导管动脉化疗栓塞治疗伴微血管侵犯的肝细胞癌患者的疗效。
World J Gastroenterol. 2017 Nov 7;23(41):7415-7424. doi: 10.3748/wjg.v23.i41.7415.
6
Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.切除术后肝细胞癌患者微血管侵犯新风险分类的预后价值
Oncotarget. 2017 Jan 17;8(3):5474-5486. doi: 10.18632/oncotarget.12547.
7
The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.根治性切除术后切缘和微血管侵犯对肝癌长期预后的影响:多机构研究。
HPB (Oxford). 2019 Aug;21(8):962-971. doi: 10.1016/j.hpb.2018.11.005. Epub 2019 Feb 2.
8
Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.R1 血管性肝切除术治疗肝细胞癌是否具有肿瘤学上的充分性?327 例连续患者的分析。
Surgery. 2019 May;165(5):897-904. doi: 10.1016/j.surg.2018.12.002. Epub 2019 Jan 26.
9
Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma.肿瘤分期中小血管侵犯对肝细胞癌的预后意义。
World J Surg Oncol. 2017 Dec 19;15(1):225. doi: 10.1186/s12957-017-1292-3.
10
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.根治性意向下接受部分肝切除术的肝细胞癌患者无病生存和总生存的预后因素。
Langenbecks Arch Surg. 2018 Nov;403(7):851-861. doi: 10.1007/s00423-018-1715-9. Epub 2018 Sep 28.

引用本文的文献

1
The Definition of the Best Margin Cutoff and Related Oncological Outcomes After Liver Resection for Hepatocellular Carcinoma: A Systematic Review.肝细胞癌肝切除术后最佳切缘界限的定义及相关肿瘤学结局:一项系统评价
Cancers (Basel). 2025 May 23;17(11):1759. doi: 10.3390/cancers17111759.
2
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).肝细胞癌微血管侵犯诊断与治疗中国专家共识(2024年版)
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30.
3
Robotic liver resection for hepatocellular carcinoma: analysis of surgical margins and clinical outcomes from a western tertiary hepatobiliary center.
肝细胞癌的机器人肝切除术:来自西方三级肝胆中心的手术切缘及临床结果分析
J Robot Surg. 2023 Apr;17(2):645-652. doi: 10.1007/s11701-022-01468-9. Epub 2022 Oct 21.
4
Prognostic Impact of Surgical Margin in Hepatectomy on Patients With Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.肝癌肝切除术中手术切缘对患者的预后影响:观察性研究的Meta分析
Front Surg. 2022 Feb 9;9:810479. doi: 10.3389/fsurg.2022.810479. eCollection 2022.
5
Anatomical nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis.孤立性肝细胞癌的解剖性与非解剖性肝切除术:一项系统评价与荟萃分析
World J Gastrointest Oncol. 2021 Nov 15;13(11):1833-1846. doi: 10.4251/wjgo.v13.i11.1833.
6
What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?除了解剖性与非解剖性肝切除之争外,肝细胞癌的最佳手术治疗方法是什么?
Surg Today. 2022 Jun;52(6):871-880. doi: 10.1007/s00595-021-02352-z. Epub 2021 Aug 14.
7
Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion.重新审视伴有微血管侵犯的肝细胞癌的手术策略
Front Oncol. 2021 May 27;11:691354. doi: 10.3389/fonc.2021.691354. eCollection 2021.